Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1262
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia ; volume:31 ; number:3 ; day:22 ; month:12 ; year:2015 ; pages:543-551 ; date:3.2016
International journal of colorectal disease ; 31, Heft 3 (22.12.2015), 543-551, 3.2016
- Beteiligte Personen und Organisationen
-
Calleja, José Luis
Delgado, Salvadora
Val, Adolfo del
Hervás, Antonio
Larraona, José Luis
Terán, Álvaro
Cucala, Mercedes
Mearin, Fermín
SpringerLink (Online service)
- DOI
-
10.1007/s00384-015-2461-x
- URN
-
urn:nbn:de:1111-201607315163
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
08.11.2024, 14:14 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Calleja, José Luis
- Delgado, Salvadora
- Val, Adolfo del
- Hervás, Antonio
- Larraona, José Luis
- Terán, Álvaro
- Cucala, Mercedes
- Mearin, Fermín
- SpringerLink (Online service)
Ähnliche Objekte (12)
Individualized anemia management enhanced by ferric pyrophosphate citrate protocol
A Cost-Utility Analysis of Ferric Derisomaltose Versus Ferric Carboxymaltose in Patients with Iron Deficiency Anemia in China
Cost-effectiveness of ferric citrate hydrate in patients with iron deficiency anemia
Treatment of anemia of inflammation with intravenous ferric carboxymaltose in a murine anemia model using heat-killed brucella abortus
Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study
Safety, pharmacokinetics, and pharmacodynamics of intravenous ferric carboxymaltose in children with iron deficiency anemia
Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
Correction to: Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study
Efficacy of oral ferric citrate hydrate treatment for anemia caused by niraparib: a case report
Tranexamic acid reduces perioperative blood transfusions following open radical cystectomy – a propensity-score matched analysis
Serial Intrauterine Transfusions for a Hydropic Fetus with Severe Anemia and Thrombocytopenia Caused by Parvovirus: Lessons Learned
High rate of inappropriate blood transfusions in the management of children with severe anemia in Ugandan hospitals
Individualized anemia management enhanced by ferric pyrophosphate citrate protocol
A Cost-Utility Analysis of Ferric Derisomaltose Versus Ferric Carboxymaltose in Patients with Iron Deficiency Anemia in China
Cost-effectiveness of ferric citrate hydrate in patients with iron deficiency anemia
Treatment of anemia of inflammation with intravenous ferric carboxymaltose in a murine anemia model using heat-killed brucella abortus
Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study
Safety, pharmacokinetics, and pharmacodynamics of intravenous ferric carboxymaltose in children with iron deficiency anemia
Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
Correction to: Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study
Efficacy of oral ferric citrate hydrate treatment for anemia caused by niraparib: a case report
Tranexamic acid reduces perioperative blood transfusions following open radical cystectomy – a propensity-score matched analysis
Serial Intrauterine Transfusions for a Hydropic Fetus with Severe Anemia and Thrombocytopenia Caused by Parvovirus: Lessons Learned
High rate of inappropriate blood transfusions in the management of children with severe anemia in Ugandan hospitals
Individualized anemia management enhanced by ferric pyrophosphate citrate protocol
A Cost-Utility Analysis of Ferric Derisomaltose Versus Ferric Carboxymaltose in Patients with Iron Deficiency Anemia in China
Cost-effectiveness of ferric citrate hydrate in patients with iron deficiency anemia
Treatment of anemia of inflammation with intravenous ferric carboxymaltose in a murine anemia model using heat-killed brucella abortus
Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study
Safety, pharmacokinetics, and pharmacodynamics of intravenous ferric carboxymaltose in children with iron deficiency anemia
Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
Correction to: Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study
Efficacy of oral ferric citrate hydrate treatment for anemia caused by niraparib: a case report
Tranexamic acid reduces perioperative blood transfusions following open radical cystectomy – a propensity-score matched analysis
Serial Intrauterine Transfusions for a Hydropic Fetus with Severe Anemia and Thrombocytopenia Caused by Parvovirus: Lessons Learned